Drug
Latanoprost 0 005
Latanoprost 0 005: highest development phase Phase 3, developed by Pfizer. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Pfizer
Trials
| Drug | Phase | Indication |
|---|---|---|
| latanoprost 0.005% NCT00800267 | Phase 3 | Ocular Hypertension |
Latest
No recent events.
Follow Latanoprost 0 005 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.